About 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide
6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide (PubChem CID 91609166) has the molecular formula C23H18BrClF4N6O3
and a molecular weight of 617.79 g/mol. Its IUPAC name is 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide.
Molecular Properties
| Compound Name | 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide |
| PubChem CID | 91609166 |
| Molecular Formula | C23H18BrClF4N6O3 |
| Molecular Weight | 617.79 g/mol |
| Exact Mass | 616.02 |
| IUPAC Name | 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide |
| SMILES | O=C(Nc1cccc(C(F)(F)F)c1)c1c(Br)cc(C/N=N/c2ncc(F)c(N3CCOCC3)n2)c(O)c1Cl |
| InChI | InChI=1S/C23H18BrClF4N6O3/c24-15-8-12(10-31-34-22-30-11-16(26)20(33-22)35-4-6-38-7-5-35)19(36)18(25)17(15)21(37)32-14-3-1-2-13(9-14)23(27,28)29/h1-3,8-9,11,36H,4-7,10H2,(H,32,37)/b34-31+ |
| InChIKey | JMEXVUJZBNSLDH-WUVHBKSUSA-N |
| XLogP | 6.13 |
| TPSA | 112.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 617.79 |
| LogP ≤ 5 | 6.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'} |
|---|
Analyze 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide?
The IUPAC name of 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide (CID 91609166) is 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide.
What is the SMILES notation for 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide?
The canonical SMILES for 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide is O=C(Nc1cccc(C(F)(F)F)c1)c1c(Br)cc(C/N=N/c2ncc(F)c(N3CCOCC3)n2)c(O)c1Cl.
What is the InChIKey of 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide?
The InChIKey is JMEXVUJZBNSLDH-WUVHBKSUSA-N. The full InChI is InChI=1S/C23H18BrClF4N6O3/c24-15-8-12(10-31-34-22-30-11-16(26)20(33-22)35-4-6-38-7-5-35)19(36)18(25)17(15)21(37)32-14-3-1-2-13(9-14)23(27,28)29/h1-3,8-9,11,36H,4-7,10H2,(H,32,37)/b34-31+.
What are the key properties of 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide?
6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide has a molecular weight of 617.79 g/mol, XLogP of 6.13, 6 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-2-chloro-4-[[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)diazenyl]methyl]-3-hydroxy-N-[3-(trifluoromethyl)phenyl]benzamide is sourced from PubChem (CID 91609166), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).